Denali Therapeutics Stock Price

Dnli) denali therapeutics currently has 122,125,581 outstanding shares. Denali therapeutics inc registered shs.

Whats Unusual With Denali Therapeutics Inc Dnli Today Find News Today Income Statement Rsi

President and ceo of denali therapeutics sold $1.00 million in stock.

Denali therapeutics stock price. Over the last 12 months, denali therapeutics's shares have ranged in value from as little as $43.87 up to $93.94. Denali therapeutics started at hold with $26 stock price target at stifel nicolaus. A form 4 filing from the u.s.

The company is focused on the discovery and development of therapies for patients with neurodegenerative diseases, including alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (als) and others. According to the issued ratings of 8 analysts in the last year, the consensus rating for denali therapeutics stock is buy based on the current 8 buy ratings for dnli. Denali therapeutics inc registered shs stock , dnli.

Securities and exchange commission on wednesday showed that watts sold 18,333 shares of denali therapeutics at a price of $54.59 per share. With denali therapeutics stock trading at $46.26 per share, the total value of denali therapeutics stock (market capitalization) is $6.43b. A popular way to gauge a stock's volatility is its beta.

Denali therapeutics nasdaq updated nov 26, 2021 9:13 pm. Ryan watts, president and ceo at denali therapeutics (nasdaq:dnli), made a large insider sell on september 1, according to a new sec filing. View the latest denali therapeutics inc.

Ryan watts, president and ceo at denali therapeutics (nasdaq:dnli), made a large insider sell on september 1,. 19, 2020 at 7:40 a.m. Stock analysis for denali therapeutics inc (dnli:nasdaq gs) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Denali therapeutics share price volatility. Is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Evercore isi has the highest price target set, predicting dnli will reach $111.00 in the next twelve months.

We're not expecting denali therapeutics to pay a dividend over the next 12 months. (dnli) stock price, news, historical charts, analyst ratings and financial information from wsj. Dnli denali therapeutics — stock price and discussion | stocktwits.